Tscan Therapeutics Inc (TCRX)

Apr 01, 2025

Monitoring Gentherm Inc (THRM) after recent insider movements - knoxdaily.com

Apr 01, 2025

Apr 01, 2025

TScan Therapeutics, Inc. (NASDAQ:TCRX) Short Interest Update - Defense World

Apr 01, 2025

Mar 31, 2025

TScan Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference - The Manila Times

Mar 31, 2025

Mar 31, 2025

Exclusive Look: TScan Reveals Latest Cancer Therapy Progress at Major Healthcare Conference - Stock Titan

Mar 31, 2025

Mar 28, 2025

Tscan Therapeutics Inc [TCRX] Shares Fall Approximately -81.72% Over the Year - Knox Daily

Mar 28, 2025

Mar 27, 2025

TScan Therapeutics Appoints Commercial Leader Stephen Camiolo as Senior Vice President, Market Access - Quantisnow

Mar 27, 2025

Mar 27, 2025

Cell Therapy Veteran With 16 Successful Launches Joins TScan Leadership - Stock Titan

Mar 27, 2025

Mar 17, 2025

Analysts Set TScan Therapeutics, Inc. (NASDAQ:TCRX) PT at $9.33 - Defense World

Mar 17, 2025

Mar 16, 2025

TScan Therapeutics (NASDAQ:TCRX) Earns Overweight Rating from Morgan Stanley - Defense World

Mar 16, 2025

Mar 14, 2025

Weekly Investment Analysts’ Ratings Changes for TScan Therapeutics (TCRX) - Defense World

Mar 14, 2025

Mar 14, 2025

TScan Therapeutics’ SWOT analysis: biotech stock navigates clinical milestones By Investing.com - Investing.com Australia

Mar 14, 2025

Mar 13, 2025

HC Wainwright Expects Weaker Earnings for TScan Therapeutics - MarketBeat

Mar 13, 2025

Mar 12, 2025

Positive Buy Rating for TScan Therapeutics Driven by Promising Clinical Data and Strong Financial Position - TipRanks

Mar 12, 2025

Mar 12, 2025

TScan Therapeutics’ SWOT analysis: biotech stock navigates clinical milestones - Investing.com India

Mar 12, 2025

Mar 12, 2025

Head to Head Analysis: TScan Therapeutics (NASDAQ:TCRX) versus Novavax (NASDAQ:NVAX) - Defense World

Mar 12, 2025

Mar 11, 2025

Analysts Set Expectations for TCRX FY2029 Earnings - MarketBeat

Mar 11, 2025

Mar 11, 2025

TScan Therapeutics Reports 2024 Financial Results and Progress - TipRanks

Mar 11, 2025

Mar 10, 2025

Q2 EPS Estimate for TScan Therapeutics Lowered by Analyst - Defense World

Mar 10, 2025

Mar 10, 2025

Wedbush Equities Analysts Cut Earnings Estimates for TCRX - Defense World

Mar 10, 2025

Mar 09, 2025

Research Analysts Set Expectations for TCRX FY2029 Earnings - Defense World

Mar 09, 2025

Mar 09, 2025

TScan Therapeutics’ (TCRX) Buy Rating Reiterated at HC Wainwright - Defense World

Mar 09, 2025

Mar 09, 2025

Barclays Issues Pessimistic Forecast for TScan Therapeutics (NASDAQ:TCRX) Stock Price - Defense World

Mar 09, 2025

Mar 07, 2025

TScan: 2 Major Milestones Of TSC-101 To Carry Tide In 2025 (NASDAQ:TCRX) - Seeking Alpha

Mar 07, 2025

Mar 07, 2025

HC Wainwright Reiterates "Buy" Rating for TScan Therapeutics (NASDAQ:TCRX) - MarketBeat

Mar 07, 2025

Mar 07, 2025

TScan Therapeutics price target lowered to $3 from $14 at Barclays - TipRanks

Mar 07, 2025

Mar 07, 2025

Needham & Company LLC Issues Pessimistic Forecast for TScan Therapeutics (NASDAQ:TCRX) Stock Price - Defense World

Mar 07, 2025

Mar 07, 2025

TScan Therapeutics (NASDAQ:TCRX) Earns Outperform Rating from Wedbush - Defense World

Mar 07, 2025

Mar 07, 2025

H.C. Wainwright maintains $15 target on Tscan shares By Investing.com - Investing.com Canada

Mar 07, 2025

Mar 06, 2025

TCR Therapy Clinical Trial Pipeline Accelerates as 80+ Pharma Companies Rigorously Developing Drugs for the Market Entry | DelveInsight - GlobeNewswire Inc.

Mar 06, 2025

Mar 06, 2025

H.C. Wainwright maintains $15 target on Tscan shares - Investing.com India

Mar 06, 2025

Mar 06, 2025

Breaking Down TScan Therapeutics: 4 Analysts Share Their Views - Benzinga

Mar 06, 2025

Mar 05, 2025

TScan Therapeutics Inc Files For Mixed Shelf Of Up To $300 Million -March 05, 2025 at 04:54 pm EST - Marketscreener.com

Mar 05, 2025

Mar 05, 2025

Tscan Therapeutics earnings missed, revenue fell short of estimates By Investing.com - Investing.com UK

Mar 05, 2025

Mar 05, 2025

TScan Therapeutics reports Q4 EPS (30c), consensus (28c) - TipRanks

Mar 05, 2025

Mar 05, 2025

TScan Therapeutics, Inc. (TCRX) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

Mar 05, 2025

Mar 05, 2025

TScan Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 05, 2025

Mar 05, 2025

TScan Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Manila Times

Mar 05, 2025

Mar 04, 2025

TScan Therapeutics (NASDAQ:TCRX) Stock Price Down 11.9% – Here’s What Happened - Defense World

Mar 04, 2025

Feb 27, 2025

TScan Therapeutics Announces Upcoming Presentation at the TD Cowen 45th Annual Health Care Conference - The Manila Times

Feb 27, 2025

Feb 27, 2025

How Will TScan's Cancer Therapy Pipeline Impress Investors at Major Healthcare Conference? - Stock Titan

Feb 27, 2025

Feb 18, 2025

TScan Therapeutics to Participate in the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference - GlobeNewswire

Feb 18, 2025

Feb 18, 2025

Inside TScan's Revolutionary TCR Cell Therapy Pipeline: CEO Conference Presentation Revealed - StockTitan

Feb 18, 2025

Feb 14, 2025

abrdn plc Has $2.69 Million Stake in TScan Therapeutics, Inc. (NASDAQ:TCRX) - MarketBeat

Feb 14, 2025

Feb 10, 2025

TScan Therapeutics: Finding Their Footing After An Eventful ASH Meeting (NASDAQ:TCRX) - Seeking Alpha

Feb 10, 2025